MyAverix Finance
US · Healthcare
Agios Pharm (AGIO)
Biotechnology
Agios Pharm (AGIO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AGIO
Agios Pharm (AGIO) — FAQ
What is AGIO's P/E ratio?
The price-to-earnings (P/E) ratio for Agios Pharm (AGIO) is 18.00 (data as of 2026-03-23).
Does Agios Pharm pay a dividend?
Dividend yield is not available in the current snapshot for Agios Pharm (AGIO). Check the MyAverix Finance app for the latest dividend data.
What sector is Agios Pharm in?
Agios Pharm (AGIO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is AGIO listed on?
AGIO is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.